NBIX icon

Neurocrine Biosciences

424 hedge funds and large institutions have $8.35B invested in Neurocrine Biosciences in 2022 Q1 according to their latest regulatory filings, with 68 funds opening new positions, 161 increasing their positions, 143 reducing their positions, and 43 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
424
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
5
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$89.6M
Puts
$79.5M
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
76
$16.9M
77
$16.6M
78
$16M
79
$15.1M
80
$14.6M
81
$14.6M
82
$14.5M
83
$14.4M
84
$14.2M
85
$13.3M
86
$13.2M
87
$13.2M
88
$12.7M
89
$12.4M
90
$11.7M
91
$11.7M
92
$11.5M
93
$11.3M
94
$10.8M
95
$9.9M
96
$9.84M
97
$9.73M
98
$9.71M
99
$9.67M
100
$9.34M